Biberach an der Riss, Germany

Bart Herlé

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Bart Herlé: Innovator in Antiparasitic Compounds

Introduction

Bart Herlé is a notable inventor based in Biberach an der Riss, Germany. He has made significant contributions to the field of antiparasitic agents, holding a total of 4 patents. His work focuses on developing compounds that can effectively treat and prevent parasitic infections in animals.

Latest Patents

Among his latest patents, Bart Herlé has developed cyclopropyl-(hetero)aryl-substituted ethylsulphonyl-pyridine derivatives. This invention relates to compounds that can be utilized as antiparasitic agents for the treatment, prevention, and control of parasitic infections and infestations in animals. Another significant patent involves anthelmintic heterocyclic compounds, which provide methods for treating, controlling, or preventing parasitic infestations or infections in animals by administering effective amounts of these compounds.

Career Highlights

Bart has worked with prominent companies in the veterinary field, including Boehringer Ingelheim Animal Health USA Inc. and Boehringer Ingelheim Vetmedica GmbH. His experience in these organizations has allowed him to contribute to the development of innovative solutions for animal health.

Collaborations

Throughout his career, Bart has collaborated with notable professionals such as Hannes Fiepko Koolman and Alan Long. These collaborations have further enhanced his research and development efforts in the field of antiparasitic compounds.

Conclusion

Bart Herlé's innovative work in developing antiparasitic agents showcases his commitment to improving animal health. His contributions through patents and collaborations highlight the importance of research in combating parasitic infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…